We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.41%
10 Year Est. Return
AUM
$14.6B
AUM Growth
-$399M
Cap. Flow
-$1.09B
Cap. Flow %
-7.42%
Top 10 Hldgs %
21.87%
Holding
344
New
64
Increased
107
Reduced
100
Closed
73

Sector Composition

Rank Sector Weight
1 Healthcare 20.39%
2 Technology 17.68%
3 Consumer Discretionary 17.15%
4 Industrials 11.44%
5 Financials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$454M 3.1%
19,546,364
-1,672,680
-8% -$35.6M
BIIB icon
2
Biogen
BIIB
$29.9B
$425M 2.9%
1,346,860
+14,295
+1% +$4.3M
GILD icon
3
Gilead Sciences
GILD
$161B
$399M 2.73%
4,810,766
-304,123
-6% -$23.7M
PXD
4
DELISTED
Pioneer Natural Resource Co.
PXD
$315M 2.15%
1,371,289
+8,228
+0.6% +$1.7M
HAL icon
5
Halliburton
HAL
$27.9B
$282M 1.92%
3,965,168
+630,822
+19% +$40.4M
PPG icon
6
PPG Industries
PPG
$25.9B
$277M 1.89%
2,631,786
+251,986
+11% +$25M
NKE icon
7
Nike
NKE
$61.9B
$274M 1.87%
7,074,126
-64,708
-0.9% -$2.41M
DAL icon
8
Delta Air Lines
DAL
$55.9B
$271M 1.85%
7,008,063
-64,642
-0.9% -$2.44M
SBUX icon
9
Starbucks
SBUX
$118B
$253M 1.73%
6,547,736
-59,996
-0.9% -$2.18M
MA icon
10
Mastercard
MA
$477B
$251M 1.71%
3,410,396
+137,950
+4% +$10.2M
AGN
11
DELISTED
Allergan plc
AGN
$238M 1.63%
1,066,402
-192,307
-15% -$39.8M
BHC icon
12
Bausch Health
BHC
$1.65B
$228M 1.56%
1,809,631
+198,317
+12% +$25.3M
LVS icon
13
Las Vegas Sands
LVS
$30.5B
$220M 1.5%
2,887,723
+29,498
+1% +$2.24M
V icon
14
Visa
V
$677B
$220M 1.5%
4,168,404
+337,064
+9% +$17.6M
META icon
15
Meta Platforms (Facebook)
META
$1.51T
$212M 1.45%
3,144,991
+384,581
+14% +$23.7M
MCK icon
16
McKesson
MCK
$98.5B
$210M 1.43%
1,125,159
-61,429
-5% -$10.9M
CP icon
17
Canadian Pacific Kansas City
CP
$82B
$209M 1.43%
5,782,635
-99,080
-2% -$3.25M
DFS
18
DELISTED
Discover Financial Services
DFS
$201M 1.37%
3,245,611
-28,797
-0.9% -$1.68M
AXP icon
19
American Express
AXP
$223B
$195M 1.33%
2,052,715
-1,379
-0.1% -$124K
GOOG icon
20
Alphabet (Google) Class C
GOOG
$3.9T
$188M 1.28%
6,432,392
-5,328,446
-45% -$145M
MS icon
21
Morgan Stanley
MS
$337B
$184M 1.26%
5,690,880
+628,396
+12% +$19.4M
NOW icon
22
ServiceNow
NOW
$102B
$183M 1.25%
14,776,035
+82,065
+0.6% +$876K
NXPI icon
23
NXP Semiconductors
NXPI
$68B
$177M 1.21%
2,676,476
+1,582,307
+145% +$96.9M
HD icon
24
Home Depot
HD
$332B
$173M 1.18%
2,140,366
-19,342
-0.9% -$1.53M
EL icon
25
Estee Lauder
EL
$29B
$172M 1.18%
2,315,494
+294,839
+15% +$21.7M

Similar funds

Columbus Circle Investors's Q2 2014 Portfolio in Review

As of Q2 2014, Columbus Circle Investors held 344 positions worth $14.6B, down 2.7% from $15B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Columbus Circle Investors withdrew a net $1.09B in Q2 2014, closing 73 positions and reducing 100 holdings. Its most notable exit was Pfizer, an estimated $230M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Columbus Circle Investors opened a new position in CONTINENTAL RESOURCES INC. worth $99.2M.

  • Columbus Circle Investors's largest Q2 2014 buy was CONTINENTAL RESOURCES INC.: 1,254,904 shares worth $99.2M.
  • Columbus Circle Investors added most to NXP Semiconductors in Q2 2014, an estimated $96.9M increase.
  • Columbus Circle Investors's biggest Q2 2014 reduction was Alphabet (Google) Class C, cutting an estimated $145M.
  • Columbus Circle Investors fully exited Pfizer in Q2 2014, selling an estimated $230M.
  • Columbus Circle Investors's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2014.
  • Columbus Circle Investors opened 64 new positions and closed 73 in Q2 2014.
  • Columbus Circle Investors's portfolio value fell 2.7% quarter-over-quarter to $14.6B.

Based on Columbus Circle Investors's 13F filing for Q2 2014, filed 31 Jul 2014.